| OABI | | OmniAb, Inc. | John L. Higgins | Director | Nov 06, 2025 | Buy | $1.41 | 36,223 | 51,074 | 2,888,110 | Nov 10, 2025, 08:30 AM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | Nov 07, 2025 | Buy | $1.38 | 41,038 | 56,632 | 2,929,148 | Nov 10, 2025, 08:30 AM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Aug 07, 2025 | Option/RSU Exercise | $21.84 | 5,040 | 110,074 | 65,236 | Aug 11, 2025, 07:06 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | Jun 17, 2025 | Option/RSU Exercise | - | 20,000 | - | 2,851,887 | Jun 18, 2025, 04:14 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | May 12, 2025 | Buy | $1.44 | 65,000 | 93,600 | 2,831,887 | May 13, 2025, 05:52 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | May 01, 2025 | Option/RSU Exercise | $21.84 | 12,000 | 262,080 | 60,196 | May 05, 2025, 04:18 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | Mar 21, 2025 | Buy | $2.28 | 4,000 | 9,120 | 2,766,887 | Mar 21, 2025, 07:58 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | Mar 20, 2025 | Buy | $2.35 | 125,750 | 295,512 | 2,762,887 | Mar 20, 2025, 08:15 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | Jan 30, 2025 | Option/RSU Exercise | - | 13,172 | - | 2,637,137 | Jan 30, 2025, 06:40 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Sep 12, 2024 | Tax Payment (Shares) | $73.20 | 1,874 | 137,177 | 46,734 | Sep 16, 2024, 04:18 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Sep 12, 2024 | Option/RSU Exercise | $22.95 | 6,000 | 137,700 | 48,608 | Sep 16, 2024, 04:18 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Jul 08, 2024 | Option/RSU Exercise | $22.95 | 6,000 | 137,700 | 42,608 | Jul 10, 2024, 04:35 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | Jun 18, 2024 | Option/RSU Exercise | - | 20,000 | - | 2,623,965 | Jun 21, 2024, 05:03 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | May 14, 2024 | Option/RSU Exercise | $22.95 | 4,000 | 91,800 | 40,608 | May 16, 2024, 04:17 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | May 14, 2024 | Sale | $83.84 | 4,000 | 335,377 | 36,608 | May 16, 2024, 04:17 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | Jan 30, 2024 | Option/RSU Exercise | - | 13,173 | - | 2,352,625 | Jan 31, 2024, 07:58 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | Dec 28, 2022 | Tax Payment (Shares) | $3.66 | 25,914 | 94,845 | 2,397,255 | Jun 27, 2023, 06:33 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | Jan 04, 2023 | Tax Payment (Shares) | $3.23 | 57,803 | 186,704 | 2,339,452 | Jun 27, 2023, 06:33 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | May 23, 2023 | Option/RSU Exercise | $3.68 | 9,000 | 33,120 | 2,471,686 | May 25, 2023, 04:45 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | May 23, 2023 | Sale | $4.05 | 9,000 | 36,450 | 2,462,686 | May 25, 2023, 04:45 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | May 19, 2023 | Option/RSU Exercise | $3.68 | 1,000 | 3,680 | 2,463,686 | May 23, 2023, 04:12 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | May 19, 2023 | Sale | $4.05 | 1,000 | 4,050 | 2,462,686 | May 23, 2023, 04:12 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | May 18, 2023 | Option/RSU Exercise | $3.68 | 50,000 | 184,000 | 2,512,686 | May 19, 2023, 05:03 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | May 18, 2023 | Sale | $3.89 | 50,000 | 194,500 | 2,462,686 | May 19, 2023, 05:03 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Apr 28, 2023 | Tax Payment (Shares) | $79.88 | 4,377 | 349,635 | 34,983 | May 02, 2023, 04:49 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Apr 28, 2023 | Option/RSU Exercise | $21.85 | 16,000 | 349,600 | 39,360 | May 02, 2023, 04:49 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Director | Dec 28, 2022 | Tax Payment (Shares) | $66.29 | 5,289 | 350,608 | 417,695 | Dec 30, 2022, 05:00 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Director | Dec 16, 2022 | Sale | $61.87 | 10,000 | 618,657 | 422,984 | Dec 20, 2022, 06:36 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Director | Dec 12, 2022 | Option/RSU Exercise | $12.78 | 20,000 | 255,600 | 436,928 | Dec 14, 2022, 05:00 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Director | Dec 12, 2022 | Disposition to Issuer | $64.80 | 3,944 | 255,571 | 432,984 | Dec 14, 2022, 05:00 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Nov 30, 2022 | Tax Payment (Shares) | $72.90 | 9,803 | 714,639 | 416,928 | Dec 01, 2022, 09:42 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Nov 17, 2022 | Sale | $78.32 | 10,000 | 783,173 | 416,731 | Nov 21, 2022, 07:04 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Nov 18, 2022 | Option/RSU Exercise | $12.78 | 10,000 | 127,800 | 426,731 | Nov 21, 2022, 07:04 PM |
| OABI | | OmniAb, Inc. | John L. Higgins | Director | Nov 02, 2022 | Option/RSU Exercise | $2.52 | 246,648 | 621,553 | 2,423,169 | Nov 03, 2022, 09:15 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Sep 16, 2022 | Sale | $88.06 | 1,000 | 88,060 | 366,180 | Sep 22, 2022, 08:32 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Sep 15, 2022 | Sale | $90.00 | 2,000 | 180,000 | 367,180 | Sep 16, 2022, 07:49 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Sep 16, 2022 | Sale | $89.35 | 3,000 | 268,050 | 364,180 | Sep 16, 2022, 07:49 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Aug 10, 2022 | Option/RSU Exercise | $66.90 | 3,400 | 227,460 | 8,006 | Aug 12, 2022, 04:02 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Aug 10, 2022 | Sale | $377.11 | 1,992 | 751,194 | 7,106 | Aug 12, 2022, 04:02 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Aug 11, 2022 | Sale | $385.39 | 512 | 197,322 | 5,510 | Aug 12, 2022, 04:02 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jun 30, 2022 | Other Acquisition or Disposition | $75.84 | 164 | 12,437 | 369,180 | Jul 06, 2022, 08:00 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Jun 07, 2022 | Sale | $364.31 | 1,000 | 364,310 | 4,606 | Jun 09, 2022, 05:07 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Jun 08, 2022 | Option/RSU Exercise | $66.90 | 600 | 40,140 | 5,206 | Jun 09, 2022, 05:07 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Jun 08, 2022 | Sale | $366.09 | 600 | 219,654 | 4,606 | Jun 09, 2022, 05:07 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Jun 07, 2022 | Option/RSU Exercise | $66.90 | 1,000 | 66,900 | 5,606 | Jun 09, 2022, 05:07 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | May 09, 2022 | Option/RSU Exercise | $21.92 | 8,000 | 175,360 | 348,593 | May 10, 2022, 05:33 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 15, 2022 | Tax Payment (Shares) | $123.68 | 5,923 | 732,557 | 344,570 | Feb 16, 2022, 08:23 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 26, 2022 | Tax Payment (Shares) | $113.68 | 9,243 | 1,050,744 | 355,201 | Jan 28, 2022, 08:42 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Nov 12, 2021 | Sale | $160.50 | 3,000 | 481,500 | 335,095 | Nov 12, 2021, 07:31 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jun 30, 2021 | Other Acquisition or Disposition | $85.91 | 247 | 21,220 | 338,095 | Jul 02, 2021, 05:14 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 15, 2021 | Tax Payment (Shares) | $172.46 | 5,212 | 898,862 | 341,856 | Feb 18, 2021, 06:27 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 05, 2021 | Tax Payment (Shares) | $203.03 | 2,970 | 602,999 | 343,060 | Feb 09, 2021, 06:08 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 05, 2021 | Option/RSU Exercise | $12.16 | 114,666 | 1,394,017 | 346,030 | Feb 09, 2021, 06:08 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 05, 2021 | Sale | $203.40 | 54,666 | 11,119,228 | 286,030 | Feb 09, 2021, 06:08 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 27, 2021 | Sale | $182.00 | 40,000 | 7,280,000 | 243,422 | Jan 27, 2021, 07:04 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 25, 2021 | Tax Payment (Shares) | $156.01 | 7,441 | 1,160,870 | 243,422 | Jan 27, 2021, 07:04 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 25, 2021 | Option/RSU Exercise | $14.47 | 50,000 | 723,500 | 285,310 | Jan 27, 2021, 07:04 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 25, 2021 | Sale | $159.00 | 50,000 | 7,950,000 | 235,310 | Jan 27, 2021, 07:04 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 27, 2021 | Option/RSU Exercise | $17.66 | 70,000 | 1,236,400 | 283,422 | Jan 27, 2021, 07:04 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Dec 31, 2020 | Other Acquisition or Disposition | $84.53 | 223 | 18,851 | 235,310 | Jan 05, 2021, 08:30 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Dec 08, 2020 | Tax Payment (Shares) | $87.52 | 1,683 | 147,296 | 235,087 | Dec 09, 2020, 06:12 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Dec 08, 2020 | Option/RSU Exercise | $10.05 | 14,657 | 147,303 | 236,770 | Dec 09, 2020, 06:12 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Nov 09, 2020 | Tax Payment (Shares) | $81.77 | 2,458 | 200,991 | 222,113 | Nov 10, 2020, 07:41 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Nov 09, 2020 | Option/RSU Exercise | $10.05 | 20,000 | 201,000 | 224,571 | Nov 10, 2020, 07:41 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Nov 06, 2020 | Option/RSU Exercise | $70.35 | 5,000 | 351,750 | 9,412 | Nov 10, 2020, 04:53 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Nov 06, 2020 | Sale | $300.35 | 5,000 | 1,501,746 | 7,962 | Nov 10, 2020, 04:53 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jul 07, 2020 | Option/RSU Exercise | $70.01 | 4,315 | 302,098 | 204,571 | Jul 09, 2020, 04:28 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 15, 2019 | Tax Payment (Shares) | $120.86 | 4,917 | 594,269 | 136,981 | Apr 24, 2020, 07:22 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 13, 2020 | Tax Payment (Shares) | $95.68 | 5,009 | 479,261 | 196,730 | Feb 18, 2020, 05:11 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 13, 2020 | Option/RSU Exercise | $9.96 | 48,125 | 479,325 | 201,739 | Feb 18, 2020, 05:11 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 15, 2020 | Tax Payment (Shares) | $97.23 | 5,116 | 497,429 | 208,600 | Feb 18, 2020, 05:11 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Feb 12, 2020 | Option/RSU Exercise | $61.46 | 5,000 | 307,300 | 9,021 | Feb 14, 2020, 04:13 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Feb 12, 2020 | Sale | $205.23 | 5,000 | 1,026,135 | 4,021 | Feb 14, 2020, 04:13 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Dec 20, 2019 | Tax Payment (Shares) | $105.87 | 6,749 | 714,517 | 153,614 | Dec 26, 2019, 02:00 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jul 31, 2019 | Buy | $95.45 | 1,850 | 176,582 | 146,749 | Jul 31, 2019, 07:26 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Jun 04, 2019 | Sale | $203.67 | 5,000 | 1,018,345 | 3,526 | Jun 06, 2019, 04:30 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Jun 04, 2019 | Option/RSU Exercise | $63.03 | 5,000 | 315,150 | 8,526 | Jun 06, 2019, 04:30 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | May 31, 2019 | Buy | $108.20 | 1,000 | 108,202 | 144,899 | May 31, 2019, 07:29 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | May 14, 2019 | Buy | $113.50 | 2,500 | 283,750 | 143,899 | May 14, 2019, 07:57 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Mar 13, 2019 | Buy | $114.29 | 2,500 | 285,725 | 141,399 | Mar 15, 2019, 01:58 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 23, 2019 | Tax Payment (Shares) | $111.78 | 6,765 | 756,192 | 126,090 | Jan 25, 2019, 04:31 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 10, 2019 | Option/RSU Exercise | $16.14 | 33,790 | 545,371 | 119,209 | Jan 14, 2019, 09:16 AM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Aug 30, 2018 | Sale | $258.25 | 3,500 | 903,875 | 85,419 | Aug 31, 2018, 01:22 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Aug 23, 2018 | Option/RSU Exercise | $61.08 | 10,000 | 610,800 | 13,012 | Aug 27, 2018, 04:12 PM |
| TECH | | BIO-TECHNE Corp | John L. Higgins | Director | Aug 23, 2018 | Sale | $187.92 | 10,000 | 1,879,170 | 3,012 | Aug 27, 2018, 04:12 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Aug 17, 2018 | Option/RSU Exercise | $14.47 | 12,993 | 188,009 | 101,912 | Aug 17, 2018, 07:37 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Aug 17, 2018 | Sale | $243.00 | 12,993 | 3,157,299 | 88,919 | Aug 17, 2018, 07:37 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Aug 16, 2018 | Option/RSU Exercise | $14.47 | 3,007 | 43,511 | 110,426 | Aug 17, 2018, 07:37 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Aug 16, 2018 | Sale | $241.33 | 21,507 | 5,190,263 | 88,919 | Aug 17, 2018, 07:37 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | May 15, 2018 | Option/RSU Exercise | $16.14 | 12,405 | 200,217 | 119,824 | May 15, 2018, 06:41 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | May 15, 2018 | Sale | $179.97 | 12,405 | 2,232,491 | 107,419 | May 15, 2018, 06:41 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Mar 06, 2018 | Tax Payment (Shares) | $165.87 | 2,982 | 494,624 | 107,419 | Mar 06, 2018, 06:36 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 15, 2018 | Tax Payment (Shares) | $157.18 | 6,242 | 981,118 | 100,065 | Feb 16, 2018, 05:38 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Feb 15, 2018 | Sale | $157.03 | 9,000 | 1,413,279 | 102,700 | Feb 16, 2018, 05:38 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 24, 2018 | Sale | $165.00 | 22,500 | 3,712,500 | 111,700 | Jan 26, 2018, 05:31 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 19, 2018 | Option/RSU Exercise | $16.14 | 16,249 | 262,259 | 162,299 | Jan 22, 2018, 07:23 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Jan 19, 2018 | Sale | $153.70 | 28,099 | 4,318,906 | 146,050 | Jan 22, 2018, 07:23 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Dec 28, 2017 | Tax Payment (Shares) | $138.66 | 5,199 | 720,893 | 146,050 | Dec 29, 2017, 09:16 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Nov 17, 2017 | Sale | $140.34 | 2,258 | 316,888 | 141,284 | Nov 20, 2017, 05:01 PM |
| LGND | | LIGAND PHARMACEUTICALS INC | John L. Higgins | Chief Executive Officer | Nov 16, 2017 | Sale | $142.53 | 5,269 | 750,991 | 143,542 | Nov 17, 2017, 05:10 PM |
